Cargando…
Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats
Hyperuricemia is an independent risk factor for renal damage and promotes the progression of chronic kidney disease. In this study, we investigated the effect of I-BET151, a small-molecule inhibitor targeting the bromodomain and extraterminal (BET) proteins, on the development of hyperuricemic nephr...
Autores principales: | Xiong, Chongxiang, Deng, Jin, Wang, Xin, Shao, Xiaofei, Zhou, Qin, Zou, Hequn, Zhuang, Shougang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921804/ https://www.ncbi.nlm.nih.gov/pubmed/33664670 http://dx.doi.org/10.3389/fphar.2021.636154 |
Ejemplares similares
-
Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model
por: Wang, Xin, et al.
Publicado: (2020) -
Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy
por: Bao, Jinfang, et al.
Publicado: (2018) -
Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats
por: Liu, Na, et al.
Publicado: (2017) -
Delayed administration of suramin attenuates peritoneal fibrosis in rats
por: Xiong, Chongxiang, et al.
Publicado: (2019) -
Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis
por: Xiong, Chongxiang, et al.
Publicado: (2016)